The TAXUS ARRIVE study is a multi-center safety and surveillance study designed to to compile safety surveillance and clinical outcomes data for the TAXUS™ Express2™ Paclitaxel-Eluting Coronary Stent System in routine clinical practice and to identify low frequency TAXUS related clinical events.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
2,585
TAXUS Express™ Paclitaxel-Eluting Coronary Stent System
Rate of TAXUS stent related cardiac events at a 1-year post implant procedure as classified by the Clinical Events Committee
Time frame: 1 year post-implant procedure
Rate of TAXUS stent related cardiac events as classified by the Clinical Events Committee
Time frame: 30 days, 6 months, 2 years post-implant procedure
Rate of target vessel related cardiac events as classified by the Clinical Events Committee
Time frame: 30 days, 6 months, 1 and 2 years post-implant procedure
Rate of other TAXUS related events
Time frame: 30 days, 6 months, 1 and 2 years post-implant procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Advanced Cardiac Specialists
Gilbert, Arizona, United States
Cardiology Associates of NEA
Jonesboro, Arkansas, United States
University of California Davis Medical Center
Sacramento, California, United States
Salinas Valley Memorial Hospital
Salinas, California, United States
Good Samaritan
San Jose, California, United States
Little Company of Mary Hospital
Torrance, California, United States
Poudre Valley Hospital
Fort Collins, Colorado, United States
Hartford Hospital
Hartford, Connecticut, United States
Advanced Clinical Research Group, LLC
Juniper, Florida, United States
Florida Heart Institute
Orlando, Florida, United States
...and 40 more locations